PT-141 (Bremelanotide) is a synthetic melanocortin peptide studied in scientific research for its interaction with melanocortin receptors and related biological signaling pathways. This peptide compound has been investigated in research settings focused on neurological, endocrine, and physiological mechanisms involving melanocortin activity. PT-141 is commonly included in peptide research collections exploring receptor interactions, cellular signaling, and peptide biology. Designed for qualified laboratory and research applications, PT-141 is intended for scientific study only where applicable. Not approved for human consumption, diagnosis, treatment, or prevention of any disease.